» Articles » PMID: 36866277

Advanced Glycation End Products Regulate the Receptor of AGEs Epigenetically

Overview
Specialty Cell Biology
Date 2023 Mar 3
PMID 36866277
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced glycation end-products (AGEs) can boost their receptor of AGE (RAGE) expression through the downstream signaling pathway to facilitate AGE-RAGE interaction. In this regulation process, the primary signaling pathways are NF-κB and STAT3. However, the inhibition of these transcription factors cannot completely block the upregulation of RAGE, which indicates AGEs may also impact RAGE expression other pathways. In this study, we revealed that AGEs can exhibit epigenetic impacts on RAGE expression. Here, we used carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) to treat liver cells and discovered that AGEs can promote the demethylation of the RAGE promoter region. To verify this epigenetic modification, we employed dCAS9-DNMT3a with sgRNA to specifically modify the RAGE promoter region against the effect of carboxymethyl-lysine and carboxyethyl-lysine. The elevated RAGE expressions were partially repressed after AGE-induced hypomethylation statuses were reversed. Additionally, TET1 were also upregulated in AGE-treated cells, indicating AGEs may epigenetically modulate RAGE through the elevating TET1 level.

Citing Articles

Role of Receptor for Advanced Glycation End-Products in Endometrial Cancer: A Review.

Zglejc-Waszak K, Jozwik M, Thoene M, Wojtkiewicz J Cancers (Basel). 2024; 16(18).

PMID: 39335163 PMC: 11430655. DOI: 10.3390/cancers16183192.


Microenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics.

Zhao Y, Zhao Y, Xu B, Liu H, Chang Q J Tissue Eng. 2024; 15:20417314241253290.

PMID: 38818510 PMC: 11138198. DOI: 10.1177/20417314241253290.

References
1.
Rajasekar P, ONeill C, Eeles L, Stitt A, Medina R . Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications. J Diabetes Res. 2015; 2015:436879. PMC: 4464584. DOI: 10.1155/2015/436879. View

2.
Dawson M, Kouzarides T . Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150(1):12-27. DOI: 10.1016/j.cell.2012.06.013. View

3.
Tewari S, Zhong Q, Santos J, Kowluru R . Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53(8):4881-8. PMC: 3415280. DOI: 10.1167/iovs.12-9732. View

4.
Hogg S, Beavis P, Dawson M, Johnstone R . Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov. 2020; 19(11):776-800. DOI: 10.1038/s41573-020-0077-5. View

5.
Wang J, Zhen Y, Zhou Y, Yan S, Jiang L, Zhang L . Promoter methylation cooperates with SNPs to modulate transcription and alter UC risk. Biochem Biophys Rep. 2018; 17:17-22. PMC: 6260414. DOI: 10.1016/j.bbrep.2018.11.001. View